Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib
in patients at high risk for coronary events [ILLUMINATE trial].
New England Journal of Medicine 2007; 357:2109-22.
Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin
or ezetimibe and carotid intima-media thickness.
New England Journal of Medicine 2009; 361:2113-22.
Genest J, McPherson R, Frohlich J, et al. 2009 Canadian
Cardiovascular Society/Canadian guidelines for the diagnosis and
treatment of dyslipidemia and prevention of cardiovascular
disease in the adult - 2009 recommendations.
Canadian Journal of Cardiology 2009; 25:567-79.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.